SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-21-060129
Filing Date
2021-11-16
Accepted
2021-11-16 17:29:58
Documents
13
Period of Report
2021-11-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea150892-8ka1_inmedphar.htm   iXBRL 8-K/A 29767
  Complete submission text file 0001213900-21-060129.txt   232366

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE inm-20211110.xsd EX-101.SCH 3031
3 XBRL DEFINITION FILE inm-20211110_def.xml EX-101.DEF 26195
4 XBRL LABEL FILE inm-20211110_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inm-20211110_pre.xml EX-101.PRE 22364
6 EXTRACTED XBRL INSTANCE DOCUMENT ea150892-8ka1_inmedphar_htm.xml XML 4237
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-39685 | Film No.: 211417500
SIC: 2834 Pharmaceutical Preparations